Prophase Labs Inc (PRPH) Stock Price, Quote & News

Company Profile

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of dietary supplements under the TK supplements, including Legendz XL, a male sexual enhancement; and Triple Edge XL, an energy and stamina booster. It also develops BE-Smart Esophageal Pre-Cancer diagnostics screening test for early detection of esophageal cancer; genomics t...

Industry: Diagnostics & Research

Sector: Healthcare

Phone: 215 345 0919

Website: www.prophaselabs.com

Address:

711 Stewart Avenue, Suite 200, Garden City, United States

Finanz Aug. 17 at 8:51 PM

$PRPH How long is it going to take to see $1 of collections? Hello?

0 · Reply

Myturn Aug. 16 at 5:26 PM

$PRPH Yes, The ProPhase Labs, Inc. Special Meeting of Stockholders (the “Special Meeting”) will be held on Tuesday, September 9, 2025, at 4:00 p.m. Eastern Time, at 273 Merrick Road, Lynbrook, NY 11563.

0 · Reply

Fortheloveoftrees Aug. 16 at 12:28 AM

$PRPH looks like they pushed back the special meeting by a week a half

0 · Reply

routetrader4 Aug. 15 at 11:03 PM

$PRPH ceo said this stock should be trading in the double digits if not the 100s if you was listening to the earning call you knowwww

1 · Reply

Asr1214 Aug. 15 at 6:21 PM

$PRPH Good volume. why someone ?

1 · Reply

Trump2019 Aug. 15 at 5:33 PM

$PRPH it can pop any time now Maybe after hour runs

0 · Reply

snsnsn2 Aug. 15 at 3:37 PM

$PRPH

0 · Reply

Abs59 Aug. 15 at 2:56 PM

Long term holds. Strong potential $BDSX $HBIO $PRPH $RAYA $WLGS

0 · Reply

Abs59 Aug. 15 at 2:19 PM

New top 5 Penny Stocks to buy for me. $BDSX $RAYA $WLGS $PRPH and finally the one I’m positive on the most $HBIO

0 · Reply

HetroBabadook Aug. 14 at 11:03 PM

$PRPH im a lazy reposter @sirspanky @Alloptionsn $TNXP $PSTV $JAGX

0 · Reply

ProPhase Labs Announces Financial Results for the Three and Six Months Ended June 30, 2025

Aug 12, 2025, 8:00 AM EDT - 6 days ago

ProPhase Labs Announces Full USPTO Approval for Issuance of U.S. Patent Protecting Esophageal Adenocarcinoma Risk Assessment

Aug 11, 2025, 8:00 AM EDT - 7 days ago

ProPhase Labs Inc. to Present Second Quarter 2025 Financial Results on August 13, 2025

Jul 29, 2025, 8:00 AM EDT - 20 days ago

ProPhase Labs Announces Special Meeting of Shareholders and Filing of Preliminary Proxy Statement

Jul 23, 2025, 8:00 AM EDT - 26 days ago

ProPhase Labs Announces Closing of $3 Million Senior Secured Convertible Notes Financing

Jul 21, 2025, 8:00 AM EDT - 4 weeks ago

ProPhase Labs Board of Directors Authorizes Management to Explore Strategic Reverse Merger and Approves Crypto Treasury Initiative

Jun 26, 2025, 7:30 AM EDT - 7 weeks ago

ProPhase Labs, Inc. Receives Additional 180 Day Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule

Jun 17, 2025, 7:30 AM EDT - 2 months ago

ProPhase Labs Announces Successful Study Demonstrating Performance of BE-Smart™ Test in Detecting Esophageal Cancer

Jun 6, 2025, 7:00 AM EDT - 2 months ago

ProPhase Labs Announces Formation of Clinical Science Advisory Board to Accelerate Commercialization of BE-SmartTM Esophageal Disease Diagnostic Platform

May 20, 2025, 7:25 PM EDT - 3 months ago

ProPhase Labs, Inc. (PRPH) Q1 2025 Earnings Call Transcript

May 20, 2025, 8:00 AM EDT - 3 months ago

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2025

May 13, 2025, 8:00 AM EDT - 3 months ago

ProPhase Labs Inc. to Present First Quarter 2025 Financial Results on May 20, 2025

Mar 31, 2025, 9:08 PM EDT - 4 months ago

ProPhase Labs, Inc. (PRPH) Q4 2024 Earnings Call Transcript

Mar 31, 2025, 8:00 AM EDT - 5 months ago

ProPhase Labs, Inc. Announces Financial Results for the Year Ended December 31, 2024

Mar 27, 2025, 8:27 AM EDT - 5 months ago

ProPhase Labs Inc. to Present 2024 Year End Financial Results on March 31, 2025

Mar 7, 2025, 8:00 AM EST - 5 months ago

ProPhase Labs to Present at the Investor Summit Virtual on March 11

Feb 26, 2025, 8:00 AM EST - 6 months ago

Diamond Equity Research Releases Update Note on ProPhase Labs Inc. (NASDAQ: PRPH)

Feb 25, 2025, 8:00 AM EST - 6 months ago

ProPhase Labs Examines Strategic Opportunities to Leverage Its DTC Multi-Media Infrastructure with Telehealth Physician Networks for Prescription Drugs

Feb 20, 2025, 8:00 AM EST - 6 months ago

ProPhase Labs Announces Excellent Progress with Crown Medical Collections Targeting Over $50 Million in Net Near-Term Cash Recovery from COVID-19 Receivables

Feb 18, 2025, 8:00 AM EST - 6 months ago

ProPhase Labs hires Stuart Hollenshead as COO, the former COO and CBO of Barstool Sports

Nov 15, 2024, 2:49 PM EST - 9 months ago

ProPhase Labs, Inc. (PRPH) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 9:52 AM EST - 9 months ago

ProPhase Labs Inc. to Present Third Quarter 2024 Financial Results on November 13, 2024

Nov 7, 2024, 11:37 PM EST - 10 months ago

ProPhase Labs Announces Pricing of Public Offering of Common Stock

Oct 17, 2024, 8:00 AM EDT - 10 months ago

ProPhase Labs Announces Positive Updates on Strategic Initiatives Company Anticipates Multiple Liquidity Events in H1 2025

Aug 19, 2024, 11:10 AM EDT - 1 year ago

ProPhase Labs to Present at August 20th Virtual Investor Summit Microcap Event

Aug 14, 2024, 3:03 PM EDT - 1 year ago

ProPhase Labs, Inc. (PRPH) Q2 2024 Earnings Call Transcript

Aug 7, 2024, 8:00 AM EDT - 1 year ago

PROPHASE LABS INC. TO PRESENT SECOND QUARTER 2024 FINANCIAL RESULTS ON AUGUST 14

Jul 11, 2024, 8:00 AM EDT - 1 year ago

ProPhase Labs Announces Update on Pharmaloz Manufacturing, Inc. Progress

May 15, 2024, 10:43 AM EDT - 1 year ago

ProPhase Labs: Hidden Gem With An AI Kicker

May 9, 2024, 4:47 PM EDT - 1 year ago

ProPhase Labs, Inc. (PRPH) Q1 2024 Earnings Call Transcript

May 9, 2024, 3:40 PM EDT - 1 year ago

ProPhase Labs Announces Financial Results for the Three Months Ended March 31, 2024, and Highlights Significant Progress in its Strategic Initiatives. - Updated

Apr 25, 2024, 8:00 AM EDT - 1 year ago

ProPhase Labs to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024

Apr 16, 2024, 8:00 AM EDT - 1 year ago

ProPhase Labs Unveils Project ZenQ-AI

Apr 10, 2024, 8:00 AM EDT - 1 year ago

ProPhase Labs Seeks to Transform Esophageal Cancer Detection and Management with Launch of its BE-Smart Test in H2 2024

Apr 1, 2024, 9:00 PM EDT - 1 year ago

ProPhase Labs Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Mar 15, 2024, 5:45 PM EDT - 1 year ago

ProPhase Labs, Inc. (PRPH) Q4 2023 Earnings Call Transcript

Mar 15, 2024, 8:00 AM EDT - 1 year ago

ProPhase Labs Announces Financial Results for the Year Ended December 31, 2023 and Significant Progress in Its Strategic Initiatives

Mar 8, 2024, 8:00 AM EST - 1 year ago

PROPHASE LABS TO PRESENT 2023 YEAR END FINANCIAL RESULTS ON MARCH 15, 2024

Feb 14, 2024, 8:00 AM EST - 1 year ago

ProPhase Labs Announces Preliminary Positive Results for Dietary Supplement Equivir

Jan 23, 2024, 8:00 AM EST - 1 year ago

Pharmaloz Manufacturing Accelerates Expansion, Improves Pricing, Boosts Profitability and Secures New Contracts

Nov 9, 2023, 4:11 PM EST - 1 year ago

ProPhase Labs, Inc. (PRPH) Q3 2023 Earnings Call Transcript

Nov 2, 2023, 8:00 AM EDT - 1 year ago

ProPhase Labs to Host Third Quarter 2023 Financial Results Conference Call on Thursday, November 9, 2023 at 11:00 a.m. Eastern Time

Oct 17, 2023, 8:00 AM EDT - 1 year ago

ProPhase Labs Announces Substantial Growth Expectations for Pharmaloz Manufacturing Subsidiary due to Skyrocketing Demand for Pharmaloz Output.

Oct 12, 2023, 8:00 AM EDT - 2 years ago

ProPhase Labs to Present at The ThinkEquity Conference

Aug 12, 2023, 11:04 AM EDT - 2 years ago

ProPhase Labs, Inc. (PRPH) Q2 2023 Earnings Call Transcript

Aug 10, 2023, 10:40 AM EDT - 2 years ago

ProPhase Labs Announces Updated Conference Call Dial-in Information for Thursday August 10, 2023 at 11:00 a.m. Eastern Time for Second Quarter 2023 Financial Results Call.

Aug 2, 2023, 8:00 AM EDT - 2 years ago

ProPhase Labs to Host Second Quarter 2023 Financial Results Conference Call on Thursday, August 10, 2023 at 11:00 a.m. Eastern Time

Jun 30, 2023, 9:44 AM EDT - 2 years ago

Navidea Biopharmaceuticals rejects ProPhase Labs offer

Jun 22, 2023, 8:30 AM EDT - 2 years ago

ProPhase Labs Inc. Sets the Course for Expansion into the MENA Region with Cutting-Edge Genomic and Diagnostics Technologies

Jun 11, 2023, 1:16 AM EDT - 2 years ago

ProPhase Labs Continues To Make The Right Moves - Reiterate Strong Buy

Finanz Aug. 17 at 8:51 PM

$PRPH How long is it going to take to see $1 of collections? Hello?

0 · Reply

Myturn Aug. 16 at 5:26 PM

0 · Reply

Fortheloveoftrees Aug. 16 at 12:28 AM

$PRPH looks like they pushed back the special meeting by a week a half

0 · Reply

routetrader4 Aug. 15 at 11:03 PM

$PRPH ceo said this stock should be trading in the double digits if not the 100s if you was listening to the earning call you knowwww

1 · Reply

Asr1214 Aug. 15 at 6:21 PM

$PRPH Good volume. why someone ?

1 · Reply

Trump2019 Aug. 15 at 5:33 PM

$PRPH it can pop any time now Maybe after hour runs

0 · Reply

snsnsn2 Aug. 15 at 3:37 PM

$PRPH

0 · Reply

Abs59 Aug. 15 at 2:56 PM

Long term holds. Strong potential $BDSX $HBIO $PRPH $RAYA $WLGS

0 · Reply

Abs59 Aug. 15 at 2:19 PM

New top 5 Penny Stocks to buy for me. $BDSX $RAYA $WLGS $PRPH and finally the one I’m positive on the most $HBIO

0 · Reply

HetroBabadook Aug. 14 at 11:03 PM

$PRPH im a lazy reposter @sirspanky @Alloptionsn $TNXP $PSTV $JAGX

0 · Reply

MTF_Trader Aug. 14 at 6:38 PM

$PRPH my 2nd biggest holding $WULF did a moonshot today. Also in the crypto space. Prph will have its moment soon

2 · Reply

BEATOFtheMARKET Aug. 14 at 6:00 PM

$PRPH

0 · Reply

BEATOFtheMARKET Aug. 14 at 5:59 PM

$PRPH signal 54.5%

0 · Reply

Myturn Aug. 14 at 3:20 PM

$PRPH Per TODAY article, Esophageal cancer diagnoses are rising among young people—and there’s still no standard screening test available. ProPhase CEO, it’s time to fast-track your test and bring it to market this year!

0 · Reply

Tank510 Aug. 14 at 3:04 PM

$PRPH Fish on

0 · Reply

BobRod Aug. 14 at 2:54 PM

$PRPH this all great news!!! finally seeing some positive price action !

0 · Reply

LinneaH Aug. 14 at 2:31 PM

$PRPH

0 · Reply

StupidestTrader Aug. 14 at 2:21 PM

$PRPH interesting article. https://www.today.com/health/disease/doctor-dismissed-esophageal-cancer-rcna224707

0 · Reply

DreyOfAllTrades Aug. 14 at 1:37 PM

$PRPH The CEO talkjng the other day has me convinced hes doing everything to see this puppy go up so im in

0 · Reply

MTF_Trader Aug. 14 at 10:27 AM

$PRPH PR likely next week with more specifics on the crypto strategy. Another virtual call with Renmark the following week. Then we have BE-smart moving along nicely (should get published soon) and Crown collections will start in about 2-3 months. Not much longer until we are multiples higher than this price.

0 · Reply

d_risk Aug. 14 at 4:59 AM

$PRPH - ProPhase Labs, Inc. - 10Q - Updated Risk Factors PRPH flags heightened risk around servicing $3.3M debt with uncertain cash flow, possible asset sales or dilutive raises, ongoing Nasdaq compliance challenges including recent cure and risk of delisting, and new hurdles tied to shareholder approvals for financing that could impact liquidity. #Biotechnology #LiquidityChallenges #NasdaqCompliance #DebtServicing #FinancialRisk 🟢 Added 🟠 Removed https://d-risk.ai/PRPH/10-Q/2025-08-13

0 · Reply

flyingrocker Aug. 14 at 4:12 AM

$PRPH all of sudden everyone has millions of shares.

1 · Reply

Market Cap	14.51M
Revenue (ttm)	6.77M
Net Income (ttm)	-53.36M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-788.18%
Debt to Equity Ratio	0.00

Volume	3,577,500
Avg Vol	8,009,311
Day's Range	N/A - N/A
Shares Out	41.54M
Stochastic %K	43%
Beta	-0.48
Analysts	Hold
Price Target	$11.00